Xueguo Liu , Shasha Li , Yizhuo Zhao , Xueying Meng , Xiaojing Xing , Hong-Min Meng
{"title":"Facile fabrication of net-like fluorescent microsphere/AuNP tags for a dual-modal colorimetric/fluorescence lateral flow assay","authors":"Xueguo Liu , Shasha Li , Yizhuo Zhao , Xueying Meng , Xiaojing Xing , Hong-Min Meng","doi":"10.1016/j.talanta.2025.128553","DOIUrl":null,"url":null,"abstract":"<div><div>Lateral flow assays (LFAs) offer a simple and rapid option for diagnosis, widely utilized for point-of-care or at-home testing. However, they often suffer from low sensitivity and high false positive owing to the single output signal. Herein, we developed a dual-mode colorimetry/fluorescence LFA <em>via</em> employing a novel net-like nanprobe as a reporter tag, which was obtained by coupling the fluorescent microspheres (FMs) with gold nanoparticles (AuNPs). Upon the introduction of the target (using miRNA-21 as a model), it hybridizes with the net-like nanprobe, subsequently trapped by the capture DNA immobilized on the test line, producing a prominent visual and fluorescent signal. Benefiting from the outstanding signal amplification capability of FMs/AuNPs nanoprobe, the developed dual-mode LFA enables highly sensitive detection of miRNA-21, with a detection limit (LOD) as low as 1 pM, which is 10 times and 20 times more sensitive than conventional FMs or AuNPs-based LFA, respectively. Additionally, in comparison to the LFA with single output signal, the analytical results of the dual-mode LFA are more reliable owing to the mutual verification of two different signals. Importantly, the platform can detect miRNA-21 in complex serum samples and distinguish cancer cells from normal cells in cell extract samples analysis, determining its great potential for point-of-care tests.</div></div>","PeriodicalId":435,"journal":{"name":"Talanta","volume":"297 ","pages":"Article 128553"},"PeriodicalIF":5.6000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Talanta","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0039914025010434","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Lateral flow assays (LFAs) offer a simple and rapid option for diagnosis, widely utilized for point-of-care or at-home testing. However, they often suffer from low sensitivity and high false positive owing to the single output signal. Herein, we developed a dual-mode colorimetry/fluorescence LFA via employing a novel net-like nanprobe as a reporter tag, which was obtained by coupling the fluorescent microspheres (FMs) with gold nanoparticles (AuNPs). Upon the introduction of the target (using miRNA-21 as a model), it hybridizes with the net-like nanprobe, subsequently trapped by the capture DNA immobilized on the test line, producing a prominent visual and fluorescent signal. Benefiting from the outstanding signal amplification capability of FMs/AuNPs nanoprobe, the developed dual-mode LFA enables highly sensitive detection of miRNA-21, with a detection limit (LOD) as low as 1 pM, which is 10 times and 20 times more sensitive than conventional FMs or AuNPs-based LFA, respectively. Additionally, in comparison to the LFA with single output signal, the analytical results of the dual-mode LFA are more reliable owing to the mutual verification of two different signals. Importantly, the platform can detect miRNA-21 in complex serum samples and distinguish cancer cells from normal cells in cell extract samples analysis, determining its great potential for point-of-care tests.
期刊介绍:
Talanta provides a forum for the publication of original research papers, short communications, and critical reviews in all branches of pure and applied analytical chemistry. Papers are evaluated based on established guidelines, including the fundamental nature of the study, scientific novelty, substantial improvement or advantage over existing technology or methods, and demonstrated analytical applicability. Original research papers on fundamental studies, and on novel sensor and instrumentation developments, are encouraged. Novel or improved applications in areas such as clinical and biological chemistry, environmental analysis, geochemistry, materials science and engineering, and analytical platforms for omics development are welcome.
Analytical performance of methods should be determined, including interference and matrix effects, and methods should be validated by comparison with a standard method, or analysis of a certified reference material. Simple spiking recoveries may not be sufficient. The developed method should especially comprise information on selectivity, sensitivity, detection limits, accuracy, and reliability. However, applying official validation or robustness studies to a routine method or technique does not necessarily constitute novelty. Proper statistical treatment of the data should be provided. Relevant literature should be cited, including related publications by the authors, and authors should discuss how their proposed methodology compares with previously reported methods.